Novartis International AG Novartis Global Communications CH-4002 Basel

First Page		Document Content
$Osteopathies / Osteoporosis / Zoledronic acid / Aclasta / Hip fracture / Alendronic acid / Richard Eastell / Bone density / Novartis / Medicine / Health / Bisphosphonates$ Date: 2008-09-29 19:34:47 Osteopathies Osteoporosis Zoledronic acid Aclasta Hip fracture Alendronic acid Richard Eastell Bone density Novartis Medicine Health Bisphosphonates		Novartis International AG Novartis Global Communications CH-4002 Basel Add to Reading List Source URL: hugin.info Download Document from Source Website File Size: 94,08 KB Share Document on Facebook

$Analysis of risk factors of hip fracture with causal Bayesian networks Alex Aussem1 , Pascal Caillet2 , Zara Klemm1 , Maxime Gasse1 , Anne-Marie Schott2 , and Michel Ducher3 1$	Analysis of risk factors of hip fracture with causal Bayesian networks Alex Aussem1 , Pascal Caillet2 , Zara Klemm1 , Maxime Gasse1 , Anne-Marie Schott2 , and Michel Ducher3 1 DocID: 1uKDV - View Document
$IMPORTANT: PLEASE READ activity, such as lifting, or from minor injury that would not ordinarily fracture normal bone. Fractures usually occur at the hip, spine, or wrist and can lead not only to pain, but also to con$	IMPORTANT: PLEASE READ activity, such as lifting, or from minor injury that would not ordinarily fracture normal bone. Fractures usually occur at the hip, spine, or wrist and can lead not only to pain, but also to con DocID: 1uFBR - View Document
$Master’s Thesis Proposal Multiaxial yield behavior of human trabecular bone Background Hip fracture is a major medical problem among osteoporotic patients. Finite element (FE) analysis can improve fracture risk predic$	Master’s Thesis Proposal Multiaxial yield behavior of human trabecular bone Background Hip fracture is a major medical problem among osteoporotic patients. Finite element (FE) analysis can improve fracture risk predic DocID: 1u5Br - View Document
	www.edoriumjournals.com CASE SERIES PEER REVIEWED \| OPEN ACCESS DocID: 1rkMG - View Document
	Bo n e an d m in eral Prevalence 10 DocID: 1r6Qq - View Document